MoneyWorks4Me

Gujarat Themis Biosyn informs about outcome of board meeting

21 Nov 2022 Evaluate

Gujarat Themis Biosyn has informed that the Board of Directors at its meeting held today, considered and approved the following: Declaration of an Interim Dividend for the Financial Year 2022-23 of ? 4.40 per equity share having face value of ? 5 i.e. 88% aggregating to ? 6,39,26,289. The Record date for the same is 2nd December,2022. This may be taken as compliance under the Listing Regulations. The meeting commenced at 10:00 am and concluded at 10:51 am.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..